Table 4.
Data extracted from the studies analysed: comparative study results.
| Author | Year | No. of patients | Single centre | No. of treatment groups | Groups (e.g., A, B, and C) | Average age (yrs) | Sex (male) | Overall mortality | Graft occlusion | Graft reinfection | Amputation | Reoperation (graft + operation related) | Total length of stay (days) | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bisdas | 2011 | 33 | Y | 2 | A—ISR-cryopreserved arterial homograft [22] B—ISR-silver-coated grafts [11] |
68 (A), 61 (B) | 94.1% | 13.6% (A) 27.2% (B) |
0% (A) 9% (B) |
0% (A) 18.2% (B) |
4.5% (A) 0% (B) |
18.2% (A) 36.3% (B) |
Group A: 24 + ‐16 Group B: 16 + ‐12 |
27 (A) 18 (B) |
| Hannon | 1996 | 47 | Y | 2 | A—ISR [25] B—EAR [22] |
62 (A) 63 (B) |
— | 32% (A) 18.2% (B) |
— | 4% (A) 0% (B) |
24% (A) 13.6% (B) |
24% (A) 0% (B) |
80 (A) 56 (B) |
— |
| Oderich | 2006 | 117 | Y | 2 | A—ISR (52) B—EAR (49) |
69.4 (A) 66.3 (B) |
77% | 30.8% (A) 55.1% (B) |
11.5% (A) 51% (B) |
9.6% (A) 30.6% (B) |
0% (A) 12.2% (B) |
— | — | — |
| Pupka | 2011 | 77 | Y | 3 | A—fresh arterial allograft with immunosuppression [24] B—fresh arterial allograft without immunosuppression [26] C—silver-coated prosthesis [27] |
57.4 (A) 59.2 (B) 58.4 (C) |
96.1% | 8.3% (A) 23.1% (B) 11.1% (C) |
8.3% (A) 34.6% (B) 7.4% (C) |
0% (A) 3.8% (B) 3.7% (C) |
0% (A) 11.5% (B) 7.4% (C) |
— | — | 22.8 |
| Quinones | 1991 | 45 | N | 2 | A—ISR [9] B—EAR (35) |
76% | 24% 30 day (combined) | 33% (combined) | 8.8% (combined) | 33% (combined) | — | — | 35.5 | |
| Takano | 2014 | 8 | Y | 2 | A—ISR B—conservative management |
66 | 87.5% | 25% (combined) | — | — | — | — | — | — |
| Vogt | 1998 | 72 | Y | 2 | A—ISR-cryopreserved allograft (38) B—ISR prosthetic graft (34) |
61 (A) 63 (A) |
— | 13.2% (A) 32.4% (B) |
— | — | — | 7.9% (A) 44.1% (B) |
14 (A) 30 (B) |
— |
| Batt | 2012 | 74 | N | 2 | A—ISR (63) B—EAR [11] |
69.7 (A) 67.9 (B) |
96.3% | 60.3% (A: 5 years) 72.7% (B: 5 years) |
12.7% (A) 14.8% (B) |
4.8% (A) 0% (B) |
23 + ‐16 (combined) | 41 | ||
| Belair | 1998 | 23 | Y | 2 | A—percutaneous drain+surgery (ISR)-11 B—direct surgery (ISR)-12 |
65.9 (A) 68.75 (B) |
86.9% | 30 days: 0% (A) 50%(B) 1 yr: 9% (A) 66.6% (B) |
9.1% (A) 41.6% (B) |
36.3% (A) 33.3% (B) |
— | 27.2% (A) 25.0% (B) |
Group A: 40 + ‐17 Group B: 25 + ‐15 |
24 (A) 48 (B) |
| Lyons | 2013 | 13 | Y | 2 | A—EAR [9] B—conservative [4] |
— | 72.7% | 55.6% (A) 100% (B) |
— | — | — | — | 29 | |
| Davila | 2015 | 36 | Y | 2 | A—ISR [27] B—EAR [9] |
69 (combined) | 83.3% | 14.8% (A) 22.2% (B) |
— | — | — | — | — | 47.5 |
| Legout | 2011 | 54 | Y | 2 | A—ISR (45) B—conservative [9] |
— | — | 22.2% (A) 22.2% (B) |
— | — | — | — | — | 12 |